Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

China flag China · Delayed Price · Currency is CNY
56.80
-1.75 (-2.99%)
At close: Apr 23, 2025, 2:57 PM CST
68.05%
Market Cap 3.87B
Revenue (ttm) 276.03M
Net Income (ttm) 68.26M
Shares Out 66.17M
EPS (ttm) 1.05
PE Ratio 55.97
Forward PE n/a
Dividend 0.40 (0.68%)
Ex-Dividend Date Jun 26, 2024
Volume 1,539,574
Average Volume 1,939,490
Open 59.08
Previous Close 58.55
Day's Range 56.20 - 59.08
52-Week Range 32.49 - 59.79
Beta -0.09
RSI 65.29
Earnings Date Apr 25, 2025

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers dura membrane patches, regenerated oxidized cellulose, and craniomaxillofacial repair systems. It also offers ReDura, NeoDura, Recranio, and StypCel for neurosurgery, and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is based in Guangzhou, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 278
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301033
Full Company Profile

Financial Performance

In 2023, SHE:301033's revenue was 230.87 million, an increase of 18.24% compared to the previous year's 195.25 million. Earnings were 40.88 million, an increase of 13.89%.

Financial Statements

News

There is no news available yet.